[go: up one dir, main page]

DK0552280T3 - Inhibering af viral replikation - Google Patents

Inhibering af viral replikation

Info

Publication number
DK0552280T3
DK0552280T3 DK91919581.8T DK91919581T DK0552280T3 DK 0552280 T3 DK0552280 T3 DK 0552280T3 DK 91919581 T DK91919581 T DK 91919581T DK 0552280 T3 DK0552280 T3 DK 0552280T3
Authority
DK
Denmark
Prior art keywords
inhibition
viral replication
dna
cell
viral
Prior art date
Application number
DK91919581.8T
Other languages
English (en)
Inventor
Michael J Scolaro
Sean M Sullivan
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0552280T3 publication Critical patent/DK0552280T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91919581.8T 1990-10-09 1991-10-09 Inhibering af viral replikation DK0552280T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59525390A 1990-10-09 1990-10-09

Publications (1)

Publication Number Publication Date
DK0552280T3 true DK0552280T3 (da) 1995-08-28

Family

ID=24382446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919581.8T DK0552280T3 (da) 1990-10-09 1991-10-09 Inhibering af viral replikation

Country Status (9)

Country Link
EP (1) EP0552280B1 (da)
JP (1) JPH06504429A (da)
AT (1) ATE124457T1 (da)
AU (1) AU652006B2 (da)
CA (1) CA2093816A1 (da)
DE (1) DE69110897T2 (da)
DK (1) DK0552280T3 (da)
ES (1) ES2073777T3 (da)
WO (1) WO1992006192A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3351476B2 (ja) * 1993-01-22 2002-11-25 三菱化学株式会社 リン脂質誘導体及びそれを含有するリポソーム
WO1995016437A1 (en) * 1993-12-17 1995-06-22 Micro-Pak, Inc. Method of transmitting a biologically active material to a cell
US5962437A (en) 1994-08-29 1999-10-05 Wake Forest University Lipid analogs for treating viral infections
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
EP1423976A1 (en) 2001-08-31 2004-06-02 Thomson Licensing S.A. Sequence counter for an audio visual stream
ATE494011T1 (de) 2003-09-17 2011-01-15 Rodos Biotarget Gmbh Lipid-arzneimittel-formulierungen zur gezielten pharmakotherapie von myeloiden und lymphoiden immunzellen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0319570B1 (en) * 1987-06-26 1995-02-22 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene and use thereof
DE3742049A1 (de) * 1987-12-11 1989-06-22 Theurer Karl Eugen Herstellung und anwendung von impfstoffen und diagnostika fuer virus- und krebserkrankungen
ATE132190T1 (de) * 1988-02-26 1996-01-15 Worcester Found Ex Biology Hemmung von htlv-iii durch exogene oligonukleotide

Also Published As

Publication number Publication date
JPH06504429A (ja) 1994-05-26
ES2073777T3 (es) 1995-08-16
AU8875991A (en) 1992-04-28
ATE124457T1 (de) 1995-07-15
WO1992006192A1 (en) 1992-04-16
AU652006B2 (en) 1994-08-11
DE69110897D1 (de) 1995-08-03
EP0552280A1 (en) 1993-07-28
DE69110897T2 (de) 1995-11-30
CA2093816A1 (en) 1992-04-10
EP0552280B1 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
DK0702085T4 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
DE69535125D1 (de) Impstoff gegen felines immunodefizienz-virus
DE69819167D1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
ATE142873T1 (de) Hemmung einer virusinfektion
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
DK0552280T3 (da) Inhibering af viral replikation
ATE209685T1 (de) Gegen plrv-infektion resistente pflanzen
ES2143475T3 (es) Genes de polifenol oxidasa.
AU2001279581A1 (en) Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or dna sequence of the koc promoter
DE60233875D1 (de) Attenuierter circovirus
PT778894E (pt) Vacina da peritonite infecciosa felina.
DE60042922D1 (de) Virale expressionsvektoren für pflanzen
ES2367245T8 (es) Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
ATE335507T1 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
WO2000042063A3 (de) Peptide zur inhibierung von hbv-core-proteinen
WO2004027066A3 (fr) Protéine recombinante chimérique et diagnostic in vitro du hiv
FI964784A0 (fi) Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa
FI890231A0 (fi) Çkaerlekssigillç, aer ett çlaosç som laoses antingen med verktyg eller foer hand, men som inte kan upplaoses utan att den gaor soender.
WO2001085770A3 (en) Sentinel virus ii
FI893346A0 (fi) Icke-reverterande rna-virus.
BR9001252A (pt) Aperfeicoamento em maquina para fabricacao de facas industriais para curtume,do tipo helicoidal